Analysis shows reduced antifungal susceptibility in patients with recalcitrant dermatophytosis, implying challenges for effective treatment.
Recalcitrant dermatophytoses with reduction in antifungal susceptibility is increasingly reported in many regions worldwide. In this paper we described clinical and mycological characteristics of patients with recalcitrant dermatophytosis together with antifungal susceptibility patterns towards common antifungals in our own region. Management and clinical outcomes were also been discussed.
No takes yet. Share an insight, caveat, or question.
Saifuddin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: